AbstractHIVInternational Workshop on HIV & Women 2020CD4:CD8 ratio normalization among treatment naive womenView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Examining differences in syndemic factors by gender and sexual orientation among women, straight men, and gay, bisexual, and other men who have sex with men living with HIV in British Columbia, CanadaView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Post-Exposure Prophylaxis in victims of sexual violence. Experience at the Condesa Specialized Clinic (CSC)View Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Validating incident pregnancies among women using contraceptives and antiretroviralsView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Determinants of PrEP initiation in women at high risk for HIVView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Not recommended, but done: Breastfeeding with HIV in GermanyView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Women on anti-retroviral therapy (ART) are less likely to achieve HIV RNA <50 copies/ml compared to men – Real World Data from the National Swedish InfCareHIV CohortView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Maternal and cord plasma bioactive eicosanoid profiles differ in pregnant women living with HIV compared to HIV-negative pregnant womenView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Adolescent girls and young women: should they be formally recognized as a key population for HIV?View Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Impact of Dolutegravir based ART among Indian womenView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Vitamin D status in pregnant women living with HIV in Denmark and association with birth outcomes - A nationwide cohort studyView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Outcomes following prenatal exposure to Dolutegravir: the Dolomite-EPPICC StudyView Abstract
